Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy.

about

Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy.

Item

http://www.wikidata.org/entity/Q49718126

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Changes in bone mineral densit ...... g aromatase inhibitor therapy.

@en

Changes in bone mineral densit ...... g aromatase inhibitor therapy.

@nl

type

Item

label

Changes in bone mineral densit ...... g aromatase inhibitor therapy.

@en

Changes in bone mineral densit ...... g aromatase inhibitor therapy.

@nl

prefLabel

Changes in bone mineral densit ...... g aromatase inhibitor therapy.

@en

Changes in bone mineral densit ...... g aromatase inhibitor therapy.

@nl

P1476

Changes in bone mineral densit ...... g aromatase inhibitor therapy.

@en

P2093

Cecile A Laurent

http://www.w3.org/2001/XMLSchema#string

Charles P Quesenberry

http://www.w3.org/2001/XMLSchema#string

Janise M Roh

http://www.w3.org/2001/XMLSchema#string

Joan C Lo

http://www.w3.org/2001/XMLSchema#string

Lawrence H Kushi

http://www.w3.org/2001/XMLSchema#string

Marilyn L Kwan

http://www.w3.org/2001/XMLSchema#string

Song Yao

http://www.w3.org/2001/XMLSchema#string

P2860

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics

Bone health history in breast cancer patients on aromatase inhibitors.

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.

Aromatase inhibitors and bone health in women with breast cancer.

Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis.

ASCO 2016: highlights in breast cancer.

Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment.

Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry.

Skeletal health in breast cancer survivors.

P2888

s10549-017-4626-5

P304

523-530

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-017-4626-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1099687273

http://www.w3.org/2001/XMLSchema#string

P698

29249058

http://www.w3.org/2001/XMLSchema#string

P932

6534130

http://www.w3.org/2001/XMLSchema#string